-10.90 (-0.88%) Dr. Reddy's Laboratories’ API manufacturing plant at New York has received three observations from United States Food and Drug Administration (USFDA). The audit of API manufacturing plant at Middleburg, New York has been completed by the USFDA. The company will address three observations comprehensively within the stipulated timeline. Currently, the company does not have any sales from this plant.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.